Cargando…
Therapeutic Potential and Molecular Mechanisms of Emblica officinalis Gaertn in Countering Nephrotoxicity in Rats Induced by the Chemotherapeutic Agent Cisplatin
Emblica officinalis Gaertn. belonging to family Euphorbiaceae is commonly known as Indian gooseberry or “Amla” in India. It is used as a ‘rejuvenating herb’ in traditional system of Indian medicine. It has been shown to possess antioxidant, anti-inflammatory and anti-apoptotic effects. Thus, on the...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045924/ https://www.ncbi.nlm.nih.gov/pubmed/27752245 http://dx.doi.org/10.3389/fphar.2016.00350 |
_version_ | 1782457194809131008 |
---|---|
author | Malik, Salma Suchal, Kapil Bhatia, Jagriti Khan, Sana I. Vasisth, Swati Tomar, Ameesha Goyal, Sameer Kumar, Rajeev Arya, Dharamvir S. Ojha, Shreesh K. |
author_facet | Malik, Salma Suchal, Kapil Bhatia, Jagriti Khan, Sana I. Vasisth, Swati Tomar, Ameesha Goyal, Sameer Kumar, Rajeev Arya, Dharamvir S. Ojha, Shreesh K. |
author_sort | Malik, Salma |
collection | PubMed |
description | Emblica officinalis Gaertn. belonging to family Euphorbiaceae is commonly known as Indian gooseberry or “Amla” in India. It is used as a ‘rejuvenating herb’ in traditional system of Indian medicine. It has been shown to possess antioxidant, anti-inflammatory and anti-apoptotic effects. Thus, on the basis of its biological effects, the present study was undertaken to evaluate the protective effect of the dried fruit extract of the E. Officinalis (EO) in cisplatin-induced nephrotoxicity in rats and also to evaluate the mechanism of its nephroprotection. The study was done on male albino Wistar rats. They were divided into six groups (n = 6) viz. control, cisplatin-control, cisplatin and EO (150, 300, and 600 mg/kg; p.o. respectively in different groups) and EO only (600 mg/kg; p.o. only). EO was administered orally to the rats for a period of 10 days and on the 7th day, a single injection of cisplatin (8 mg/kg; i.p.) was administered to the cisplatin-control and EO treatment groups. The rats were sacrificed on the 10th day. Cisplatin-control rats had deranged renal function parameters and the kidney histology confirmed the presence of acute tubular necrosis. Furthermore, there were increased oxidative stress, apoptosis and inflammation along with higher expression of MAPK pathway proteins in the rat kidney from the cisplatin-control group. Contrary to this, EO (600 mg/kg) significantly normalized renal function, bolstered antioxidant status and ameliorated histological alterations. The inflammation and apoptosis were markedly lower in comparison to cisplatin-control rats. Furthermore, EO (600 mg/kg) inhibited MAPK phosphorylation which was instrumental in preserving renal function and morphology. In conclusion, the results of our study demonstrated that EO attenuated cisplatin-induced nephrotoxicity in rats through suppression of MAPK induced inflammation and apoptosis. |
format | Online Article Text |
id | pubmed-5045924 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-50459242016-10-17 Therapeutic Potential and Molecular Mechanisms of Emblica officinalis Gaertn in Countering Nephrotoxicity in Rats Induced by the Chemotherapeutic Agent Cisplatin Malik, Salma Suchal, Kapil Bhatia, Jagriti Khan, Sana I. Vasisth, Swati Tomar, Ameesha Goyal, Sameer Kumar, Rajeev Arya, Dharamvir S. Ojha, Shreesh K. Front Pharmacol Pharmacology Emblica officinalis Gaertn. belonging to family Euphorbiaceae is commonly known as Indian gooseberry or “Amla” in India. It is used as a ‘rejuvenating herb’ in traditional system of Indian medicine. It has been shown to possess antioxidant, anti-inflammatory and anti-apoptotic effects. Thus, on the basis of its biological effects, the present study was undertaken to evaluate the protective effect of the dried fruit extract of the E. Officinalis (EO) in cisplatin-induced nephrotoxicity in rats and also to evaluate the mechanism of its nephroprotection. The study was done on male albino Wistar rats. They were divided into six groups (n = 6) viz. control, cisplatin-control, cisplatin and EO (150, 300, and 600 mg/kg; p.o. respectively in different groups) and EO only (600 mg/kg; p.o. only). EO was administered orally to the rats for a period of 10 days and on the 7th day, a single injection of cisplatin (8 mg/kg; i.p.) was administered to the cisplatin-control and EO treatment groups. The rats were sacrificed on the 10th day. Cisplatin-control rats had deranged renal function parameters and the kidney histology confirmed the presence of acute tubular necrosis. Furthermore, there were increased oxidative stress, apoptosis and inflammation along with higher expression of MAPK pathway proteins in the rat kidney from the cisplatin-control group. Contrary to this, EO (600 mg/kg) significantly normalized renal function, bolstered antioxidant status and ameliorated histological alterations. The inflammation and apoptosis were markedly lower in comparison to cisplatin-control rats. Furthermore, EO (600 mg/kg) inhibited MAPK phosphorylation which was instrumental in preserving renal function and morphology. In conclusion, the results of our study demonstrated that EO attenuated cisplatin-induced nephrotoxicity in rats through suppression of MAPK induced inflammation and apoptosis. Frontiers Media S.A. 2016-10-03 /pmc/articles/PMC5045924/ /pubmed/27752245 http://dx.doi.org/10.3389/fphar.2016.00350 Text en Copyright © 2016 Malik, Suchal, Bhatia, Khan, Vasisth, Tomar, Goyal, Kumar, Arya and Ojha. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Malik, Salma Suchal, Kapil Bhatia, Jagriti Khan, Sana I. Vasisth, Swati Tomar, Ameesha Goyal, Sameer Kumar, Rajeev Arya, Dharamvir S. Ojha, Shreesh K. Therapeutic Potential and Molecular Mechanisms of Emblica officinalis Gaertn in Countering Nephrotoxicity in Rats Induced by the Chemotherapeutic Agent Cisplatin |
title | Therapeutic Potential and Molecular Mechanisms of Emblica officinalis Gaertn in Countering Nephrotoxicity in Rats Induced by the Chemotherapeutic Agent Cisplatin |
title_full | Therapeutic Potential and Molecular Mechanisms of Emblica officinalis Gaertn in Countering Nephrotoxicity in Rats Induced by the Chemotherapeutic Agent Cisplatin |
title_fullStr | Therapeutic Potential and Molecular Mechanisms of Emblica officinalis Gaertn in Countering Nephrotoxicity in Rats Induced by the Chemotherapeutic Agent Cisplatin |
title_full_unstemmed | Therapeutic Potential and Molecular Mechanisms of Emblica officinalis Gaertn in Countering Nephrotoxicity in Rats Induced by the Chemotherapeutic Agent Cisplatin |
title_short | Therapeutic Potential and Molecular Mechanisms of Emblica officinalis Gaertn in Countering Nephrotoxicity in Rats Induced by the Chemotherapeutic Agent Cisplatin |
title_sort | therapeutic potential and molecular mechanisms of emblica officinalis gaertn in countering nephrotoxicity in rats induced by the chemotherapeutic agent cisplatin |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045924/ https://www.ncbi.nlm.nih.gov/pubmed/27752245 http://dx.doi.org/10.3389/fphar.2016.00350 |
work_keys_str_mv | AT maliksalma therapeuticpotentialandmolecularmechanismsofemblicaofficinalisgaertnincounteringnephrotoxicityinratsinducedbythechemotherapeuticagentcisplatin AT suchalkapil therapeuticpotentialandmolecularmechanismsofemblicaofficinalisgaertnincounteringnephrotoxicityinratsinducedbythechemotherapeuticagentcisplatin AT bhatiajagriti therapeuticpotentialandmolecularmechanismsofemblicaofficinalisgaertnincounteringnephrotoxicityinratsinducedbythechemotherapeuticagentcisplatin AT khansanai therapeuticpotentialandmolecularmechanismsofemblicaofficinalisgaertnincounteringnephrotoxicityinratsinducedbythechemotherapeuticagentcisplatin AT vasisthswati therapeuticpotentialandmolecularmechanismsofemblicaofficinalisgaertnincounteringnephrotoxicityinratsinducedbythechemotherapeuticagentcisplatin AT tomarameesha therapeuticpotentialandmolecularmechanismsofemblicaofficinalisgaertnincounteringnephrotoxicityinratsinducedbythechemotherapeuticagentcisplatin AT goyalsameer therapeuticpotentialandmolecularmechanismsofemblicaofficinalisgaertnincounteringnephrotoxicityinratsinducedbythechemotherapeuticagentcisplatin AT kumarrajeev therapeuticpotentialandmolecularmechanismsofemblicaofficinalisgaertnincounteringnephrotoxicityinratsinducedbythechemotherapeuticagentcisplatin AT aryadharamvirs therapeuticpotentialandmolecularmechanismsofemblicaofficinalisgaertnincounteringnephrotoxicityinratsinducedbythechemotherapeuticagentcisplatin AT ojhashreeshk therapeuticpotentialandmolecularmechanismsofemblicaofficinalisgaertnincounteringnephrotoxicityinratsinducedbythechemotherapeuticagentcisplatin |